logo
Update on the Treatment of Phantom Pain
Non-Whites Get Less Aggressive Treatment of Chronic Low Back Pain, Survey Finds
New Pill Combines Ibuprofen and Oxycodone for Synergy and Convenience
FDA Panel Says COX-2 Inhibitors Should Not Be Withdrawn, Although Risks Must Be Clearly Disclosed to Patients
Fadia T. Shaya, on Clinical Decisions and Safety Data for COX-2 Inhibitors
Topics in Pain Management CME Quiz
NEWS IN BRIEF